Neoadjuvant chemotherapy with S-1 for scirrhous gastric cancer: a pilot study.
- 1 April 2003
- journal article
- case report
- Published by Springer Nature in Gastric Cancer
- Vol. 6 (1), 40-44
- https://doi.org/10.1007/s10120-003-0220-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancerGastric Cancer, 2001
- Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric CancerOncology, 2000
- Scirrhous Cancer of the Stomach which Survived for More than Five Years after Neoadjuvant Chemotherapy with UFT (uracil and tegafur) and Cisplatin.Internal Medicine, 2000
- An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal CancersOncology, 1999
- Japanese Classification of Gastric Carcinoma – 2nd English Edition –Gastric Cancer, 1998
- Japanese Classification of Gastric Carcinoma - 2nd English Edition -Gastric Cancer, 1998
- Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patientsEuropean Journal Of Cancer, 1998
- Pilot study for preoperative administration of 1-OHP to patients with advanced scirrhous type gastric cancerBiomedicine & Pharmacotherapy, 1997
- Extended surgery—Left upper abdominal exenteration plus Appleby's method—For type 4 gastric carcinomaAnnals of Surgical Oncology, 1997
- Neoadjuvant Chemotherapy in Scirrhous Cancer of the Stomach Using Uracil and Tegafur and Cisplatin.Internal Medicine, 1996